Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENADRYL | McNeil Pharmaceutical | N-005845 DISCN | 1982-01-01 | 3 products |
BENADRYL | McNeil Pharmaceutical | N-006146 DISCN | 1982-01-01 | 2 products, RLD |
BENADRYL PRESERVATIVE FREE | McNeil Pharmaceutical | N-009486 DISCN | 1982-01-01 | 1 products, RLD |
BENYLIN | Pfizer | N-006514 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
24 / 7 life extra strength pain reliever pm | OTC monograph not final | 2023-07-19 |
24/7 life allergy relief | OTC monograph final | 2023-07-19 |
acetadryl | OTC monograph not final | 2013-11-12 |
acetaflu nighttime | OTC monograph final | 2020-03-26 |
acetaflu nighttime effervescent | OTC monograph final | 2020-03-26 |
acetamax pm | OTC monograph not final | 2020-08-31 |
acetaminophen | OTC monograph not final | 2023-02-27 |
acetaminophen 500mg diphenhydramine hcl 25mg | OTC monograph not final | 2020-11-16 |
acetaminophen and diphenhydramine hcl | C200263 | 2023-12-18 |
acetaminophen and diphenhydramine hydrochloride | C200263 | 2023-12-05 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 34 | 40 | 49 | 45 | 41 | 204 |
Healthy volunteers/patients | — | — | — | 130 | 3 | 1 | 8 | 13 | 154 |
Postoperative pain | D010149 | — | G89.18 | 10 | 17 | 22 | 60 | 40 | 145 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 9 | 13 | 24 | 9 | 8 | 61 |
Migraine disorders | D008881 | EFO_0003821 | G43 | 3 | 5 | 21 | 17 | 10 | 54 |
Opioid-related disorders | D009293 | EFO_0005611 | F11 | 10 | 12 | 11 | 6 | 15 | 51 |
Low back pain | D017116 | HP_0003419 | M54.5 | — | 10 | 15 | 17 | 10 | 50 |
Patent ductus arteriosus | D004374 | HP_0001643 | Q25.0 | 2 | 13 | 12 | 9 | 17 | 49 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 5 | 15 | 5 | 8 | 9 | 41 |
Acute pain | D059787 | — | R52 | 8 | 5 | 7 | 11 | 8 | 39 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 9 | 3 | — | 8 | 22 |
Multiple myeloma | D009101 | — | C90.0 | 4 | 7 | 3 | — | 1 | 15 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 10 | 1 | — | 1 | 13 |
Leukemia | D007938 | — | C95 | 2 | 5 | 1 | — | 3 | 11 |
Lymphoma | D008223 | — | C85.9 | 2 | 4 | 2 | — | 1 | 9 |
Cocaine-related disorders | D019970 | — | F14 | 4 | 4 | 1 | — | — | 8 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 6 | 1 | — | 1 | 8 |
Colorectal neoplasms | D015179 | — | — | 2 | 5 | 1 | — | 1 | 7 |
Non-small-cell lung carcinoma | D002289 | — | — | 3 | 2 | 2 | — | — | 7 |
Plasma cell neoplasms | D054219 | — | — | 2 | 2 | 1 | — | 1 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 4 | 5 | — | — | 1 | 9 |
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 4 | — | — | — | 7 |
Graft vs host disease | D006086 | — | D89.81 | 2 | 4 | — | — | — | 5 |
Hepatitis b | D006509 | — | — | 1 | 4 | — | — | — | 5 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 4 | — | — | — | 5 |
Foot and mouth disease hand | D006232 | EFO_0007294 | B08.4 | — | 1 | — | — | 4 | 5 |
Contraception | D003267 | — | — | — | 1 | — | — | 4 | 5 |
Melanoma | D008545 | — | — | 3 | 2 | — | — | — | 4 |
Chronic disease | D002908 | — | — | 1 | 3 | — | — | 1 | 4 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug interactions | D004347 | — | — | 10 | — | — | — | 3 | 13 |
Therapeutic equivalency | D013810 | — | — | 10 | — | — | — | — | 10 |
Pharmacokinetics | D010599 | — | — | 4 | — | — | — | 1 | 5 |
Pneumonia | D011014 | EFO_0003106 | — | 1 | — | — | — | 2 | 3 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | 2 | — | — | — | 1 | 3 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | — | — | — | 1 | 2 |
Food-drug interactions | D018565 | — | — | 2 | — | — | — | — | 2 |
Alcohol-related disorders | D019973 | — | F10 | 1 | — | — | — | 1 | 2 |
Gallstones | D042882 | EFO_0004210 | — | 1 | — | — | — | 1 | 2 |
Abdominal aortic aneurysm | D017544 | EFO_0004214 | — | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pelvic pain | D017699 | — | — | — | — | — | — | 5 | 5 |
Trismus | D014313 | — | — | — | — | — | — | 3 | 3 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 3 | 3 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 2 | 2 |
Prolapse | D011391 | — | — | — | — | — | — | 2 | 2 |
Anaphylaxis | D000707 | — | T78.2 | — | — | — | — | 2 | 2 |
Lacerations | D022125 | — | — | — | — | — | — | 2 | 2 |
Laparoscopic cholecystectomy | D017081 | — | — | — | — | — | — | 2 | 2 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 2 | 2 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | — | — | — | — | 2 | 2 |
Drug common name | Diphenhydramine |
INN | diphenhydramine |
Description | Diphenhydramine is an ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. It has a role as a H1-receptor antagonist, an antiemetic, a sedative, an anti-allergic agent, a muscarinic antagonist, an antiparkinson drug, an antipruritic drug, a local anaesthetic, an antidyskinesia agent, an antitussive and a oneirogen. It is an ether and a tertiary amino compound. |
Classification | Small molecule |
Drug class | first-generation antihistamine (ethanolamine), anticholinergic, hallucinogen (deliriant) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)CCOC(c1ccccc1)c1ccccc1 |
PDB | — |
CAS-ID | 58-73-1 |
RxCUI | — |
ChEMBL ID | CHEMBL657 |
ChEBI ID | 4636 |
PubChem CID | 3100 |
DrugBank | DB01075 |
UNII ID | 8GTS82S83M (ChemIDplus, GSRS) |